p57 Kip2 Antibody [HRP]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-28707H
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunoprecipitation, Western Blot (Negative)
Label
HRP
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for p57 Kip2 Antibody [HRP]
Immunogen
The immunogen recognized by this antibody maps to a region between residue 266 and 316 of human cyclin-dependent kinase inhibitor p57 using the numbering given in entry NP_000067.1 (GeneID 1028).
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Applications for p57 Kip2 Antibody [HRP]
Application
Recommended Usage
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Western Blot (Negative)
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS
Preservative
No Preservative
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: p57 Kip2
Alternate Names
Beckwith-Wiedemann syndrome, BWS, cyclin-dependent kinase inhibitor 1C, cyclin-dependent kinase inhibitor 1C (p57, Kip2), Cyclin-dependent kinase inhibitor p57, KIP2BWCR, p57, p57Kip2, WBS
Gene Symbol
CDKN1C
Additional p57 Kip2 Products
Product Documents for p57 Kip2 Antibody [HRP]
Product Specific Notices for p57 Kip2 Antibody [HRP]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...